Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Chemmedchem|November 30, 2021
Movement of Mitochondria with Mutant DNA through Extracellular Vesicles Helps Cancer Cells Acquire ChemoresistanceEtna Abad, Alex LyakhovichCell Death and Differentiation|February 21, 2024
Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control?Ana Janic, Etna Abad, Ivano AmelioCancer Letters|January 23, 2020
DNA damage response and resistance of cancer stem cellsEtna Abad, Dmitry Graifer, Alex LyakhovichAntioxidants & Redox Signaling|July 8, 2017
Reactive Oxygen Species-Mediated Autophagy Defines the Fate of Cancer Stem CellsMatilde E Lleonart, Etna Abad, Dmitry Graifer, et al.The FEBS Journal|October 22, 2020
Enhanced DNA damage response through RAD50 in triple negative breast cancer resistant and cancer stem-like cells contributes to chemoresistanceEtna Abad, Laia Civit, David Potesil, et al.Molecular & Cellular Proteomics : MCP|October 31, 2018
Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast CancerEtna Abad, Yoelsis García-Mayea, Cristina Mir, et al.Cancer Letters|December 14, 2020
Identification of metabolic changes leading to cancer susceptibility in Fanconi anemia cellsEtna Abad, Sara Samino, Robert L Grodzicki, et al.Cancer Letters|June 24, 2025
A novel mismatch repair deficient lung adenocarcinoma model for immunotherapy researchIvan Zadra, Etna Abad, Anastasia Krasko, et al.Journal of Experimental & Clinical Cancer Research : CR|April 29, 2024
The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instabilityEtna Abad, Jérémy Sandoz, Gerard Romero, et al.Cell Death & Disease|October 21, 2020
Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesisSarah A Best, Cassandra J Vandenberg, Etna Abad, et al.Pageof 2